The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity. The dramatic ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Analyst Tim Anderson from Bank of America Securities reiterated a Hold rating on Pfizer (PFE – Research Report) and keeping the price target at ...

A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Devart has been a household name in data management tools. Currently, it’s trusted by over 500,000 users, including 65% of Fortune 100 companies and industry giants like SpaceX and Pfizer. Over the ...

The stock market bounced around in the final half-hour of trading as markets reacted to comments from President Donald Trump ...